By Tom Jones | BDS Analytics – Director of Analytics | December 6, 2016
Dec. 6, 2016—When Oregon implemented more stringent testing and packaging regulations for its nascent cannabis market on October 1, many in the industry speculated that the new rules would have a negative impact on the market. Now, with the availability of BDS Analytics’ detailed data for the month of October, we can objectively review the effect. Unfortunately, the numbers show that those pessimistic predictions were accurate. Oregon dispensaries’ cannabis sales dropped 8.5 percent from September to October, to $29.5 million, the first time the market fell below $30 million since May. (Sales spiked to $31.5 million in June when adult-use dispensaries began selling concentrates and edibles, and averaged $32.6 million per month July through September.)
Recent Post
- Fastest Growing Disposable Vape Brands
- Maximizing 4/20 Success: Insights and Strategies for Cannabis Retailers and Brands
- Emerald Earnings: St. Patrick’s Day’s Surprising Impact on Cannabis Sales
- Small Categories, Big Wins: How to Optimize Cannabis Retail for Valentine’s Day
- Redefining Growth: Innovative Strategies for Cannabis Brands in a Price-Compressed Market